M
Michael D. Schreiber
Researcher at University of Chicago
Publications - 92
Citations - 3563
Michael D. Schreiber is an academic researcher from University of Chicago. The author has contributed to research in topics: Bronchopulmonary dysplasia & Bayley Scales of Infant Development. The author has an hindex of 26, co-authored 88 publications receiving 3184 citations. Previous affiliations of Michael D. Schreiber include University of California, San Francisco & University of Illinois at Chicago.
Papers
More filters
Journal ArticleDOI
Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn
Jesse D. Roberts,Jeffrey R. Fineman,Frederick C. Morin,Philip W. Shaul,Stephen Rimar,Michael D. Schreiber,Richard A. Polin,Maurice S. Zwass,Michael M. Zayek,Ian Gross,Michael A. Heymann,Warren M. Zapol,Kajori G. Thusu,Thomas M. Zellers,Mark E. Wylam,Alan M. Zaslavsky +15 more
TL;DR: Inhaled nitric oxide improves systemic oxygenation in infants with persistent pulmonary hypertension and may reduce the need for more invasive treatments.
Journal ArticleDOI
Inhaled nitric oxide in premature infants with the respiratory distress syndrome.
Michael D. Schreiber,Karen Gin-Mestan,Jeremy D. Marks,Dezheng Huo,Grace M. Lee,Pimol Srisuparp +5 more
TL;DR: The use of inhaled nitric oxide in premature infants with the respiratory distress syndrome decreases the incidence of chronic lung disease and death.
Journal ArticleDOI
Neurodevelopmental Outcomes of Premature Infants Treated with Inhaled Nitric Oxide
TL;DR: Premature infants treated with inhaled nitric oxide have improved neurodevelopmental outcomes at two years of corrected age, primarily due to a 47 percent decrease in the risk of cognitive impairment.
Journal ArticleDOI
Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data
Filip Cools,Lisa M. Askie,Martin Offringa,Jeanette M. Asselin,Sandra Calvert,Sherry E. Courtney,Carlo Dani,David J. Durand,Dale R. Gerstmann,David J Henderson‐Smart,Neil Marlow,Janet L. Peacock,J. Jane Pillow,Roger F. Soll,Ulrich Thome,Patrick Truffert,Michael D. Schreiber,Patrick Van Reempts,Valentina Vendettuoli,Giovanni Vento +19 more
TL;DR: The results do not support selection of preterm infants for HFOV on the basis of gestational age, birthweight for gestation, initial lung disease severity, or exposure to antenatal corticosteroids.
Journal ArticleDOI
Inhaled Nitric Oxide in Preterm Infants: An Individual-Patient Data Meta-analysis of Randomized Trials
Lisa M. Askie,Roberta A. Ballard,Gary Cutter,Carlo Dani,Diana Elbourne,David Field,Jean-Michel Hascoet,Anna Maria Hibbs,John Kinsella,Jean-Christophe Mercier,Wade Rich,Michael D. Schreiber,Pimol Wongsiridej,Nim V Subhedar,Krisa P. Van Meurs,Merryn Voysey,Keith J. Barrington,Richard A. Ehrenkranz,Neil N. Finer +18 more
TL;DR: Routine use of iNO for treatment of respiratory failure in preterm infants cannot be recommended and the use of a higher starting dose might be associated with improved outcome, but because there were differences in the designs of these trials, it requires further examination.